HIV/AIDS
Data on HIV/AIDS published by R. Vanbrummelen and colleagues
Published in AIDS Weekly and Law, November 1st, 2007
"The patients ( n = 253) from four different trial centres were randomly divided into two groups, active and placebo, and regularly assessed by clinical and safety parameters. After six months from commencement, clinically and statistically significant differences were observed. The females of the active treatment group presented with a decreased level of decline in their CD4 counts ( p = 0.0027), so also the patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly and Law
Source: AIDS Weekly and Law (2007-11-01)
More Articles from AIDS Weekly and Law
- HIV/AIDS
Research results from University of East Anglia update understanding of HIV/AIDS - HIV/AIDS
Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF - Terrorism
Charles S. Cohen, Pacific Design Center Augment Their Support for AIDS Walk Los Angeles - Biomedicine
Study findings from Columbia University, Department of Biomedical Informatics provide new insights into biomedicine - Gene Therapy
New findings from University of Amsterdam, Microbiology Center describe advances in gene therapy - Gene Therapy
Recent findings from University of Pittsburgh highlight research in gene therapy - More from this issue of AIDS Weekly and Law
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
